Buckingham Capital Management (New York)’s Quest Diagnostics DGX Stock Holding History

Buckingham Capital Management (New York)’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-155,327	Closed	-$11.9M	–	105
2015 Q1	$11.9M	Buy	155,327 +980	+0.6%	+$70.2K	1.04%	35
2014 Q4	$10.4M	Buy	154,347 +22,380	+17%	+$1.41M	0.92%	40
2014 Q3	$8.01M	Sell	131,967 -853	-0.6%	-$52.6K	0.71%	56
2014 Q2	$7.79M	Buy	132,820 +29,730	+29%	+$1.74M	0.63%	59
2014 Q1	$5.97M	Sell	103,090 -34,280	-25%	-$1.84M	0.55%	63
2013 Q4	$7.36M	Buy	137,370 +53,270	+63%	+$3.16M	0.74%	53
2013 Q3	$5.2M	Buy	84,100 +25,800	+44%	+$1.54M	0.5%	70
2013 Q2	$3.54M	Buy	+58,300	New	+$3.47M	0.34%	85

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Buckingham Capital Management (New York)'s DGX Position: Q2 2015 in Review

Buckingham Capital Management (New York) sold out of Quest Diagnostics (DGX) in Q2 2015, closing a stake of 155,327 shares — an estimated $11.9M sold.

Buckingham Capital Management (New York) first reported a position in DGX in Q2 2013 and held it in 8 quarters. The position peaked at $11.9M in Q1 2015. 542 funds tracked by Wall St. Rank hold DGX as of Q2 2015.

Buckingham Capital Management (New York) reported no remaining Quest Diagnostics position as of Q2 2015 after selling out during the quarter.
Buckingham Capital Management (New York) sold 155,327 Quest Diagnostics shares in Q2 2015, an estimated $11.9M.
Buckingham Capital Management (New York) first reported a position in Quest Diagnostics in Q2 2013 and held it in 8 quarters.
Buckingham Capital Management (New York)'s Quest Diagnostics position peaked at $11.9M in Q1 2015.
542 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2015.

Based on Buckingham Capital Management (New York)'s 13F filing for Q2 2015, filed 24 Aug 2015.